Message from the CEO
Our approach to sustainability is to do business in a manner that contributes to a healthy environment, to strong communities and to economic prosperity.
Please explore our sustainability website, which illustrates our commitments, challenges and performance. And, once you've had the opportunity to explore it, we would appreciate any feedback you have on our sustainability performance.
We have a long history of public reporting and, since its inception, we have used the Global Reporting Initiative to help guide us. Our Sustainability 2010 Goals continue to drive our efforts to improve the triple bottom line of economic, social and environmental benefits. Like all of our business practices, the Sustainability 2010 Goals flow from the Bristol-Myers Squibb Mission - to discover, develop and deliver innovative medicines that help patients prevail over serious diseases - and from our Commitment to all of our stakeholders: "To act on our belief that the priceless ingredient of every product is the honor and integrity of its maker."
Through our mission and commitment, our environment, health and safety policy, goals and actions, we are committed to doing our part. I am particularly proud of our commitment to achieving the Green Building Council's Leadership in Energy and Environmental Design certification at our state-of-the-art biologics manufacturing facility under construction in Devens, Massachusetts.
As a leading next-generation BioPharma company, Bristol-Myers Squibb is focused on doing the right thing for patients, employees, shareholders and the communities where we live and work. We must intensify our efforts to improve access to medicines and health care in general. We must encourage innovation, in part by upholding and advancing intellectual property rights. And we must operate efficiently and profitably so we can continue to discover and develop new medicines for serious medical needs, while also advancing safety and environmental protection.
Global health care challenges are daunting. We recognize that we must work together with governments, payers, patients, health care providers and other stakeholders to develop workable and sustainable solutions. It's a challenging journey, but, as we say, "Together we can prevail."
James M. Cornelius
Chairman and CEO
Bristol-Myers Squibb